Pralidoxime in organophosphorus poisoning
INTRODUCTION: Pralidoxime are enzyme reactivator that are known to reactivate the phosphorylated acetylcholinesterase by binding to the organophosphorus molecule. The use of oximes in acute organophosphorus poisoning has been a controversial subjects for over two decades. This study was conduc...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nepal Medical Association
2010-12-01
|
Series: | Journal of Nepal Medical Association |
Online Access: | http://jnma.com.np/jnma/index.php/jnma/article/view/62 |
id |
doaj-4eb31ab8f9b84cc29406425d28fbd1d6 |
---|---|
record_format |
Article |
spelling |
doaj-4eb31ab8f9b84cc29406425d28fbd1d62020-11-24T21:27:45ZengNepal Medical AssociationJournal of Nepal Medical Association0028-27151815-672X2010-12-015018010.31729/jnma.6262Pralidoxime in organophosphorus poisoningN R Simkhada0KK Kafle1PN Prasad2Department of Clinical Pharmacology, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, KathmanduDepartment of Clinical Pharmacology, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, NepalDepartment of General Practice and Emergency, Institute of Medicine, Tribhuvan University Teaching Hospital, Maharajgunj, Kathmandu, Nepal INTRODUCTION: Pralidoxime are enzyme reactivator that are known to reactivate the phosphorylated acetylcholinesterase by binding to the organophosphorus molecule. The use of oximes in acute organophosphorus poisoning has been a controversial subjects for over two decades. This study was conducted with the objective to find out the estimation of serum cholinesterase and use of pralidoxime in organophosphorus poisoning. METHODS: A prospective analysis of all organophosphorus poisoning cases presented at the Emergency Department, Tribhuvan University Teaching Hospital for seven months was done. RESULTS: Out of 26 cases about 60% of poisoning cases were monitored for pseudocholinesterase level. About 50% of them had pseudocholinesterase level within normal limit and 20% had less than 10% of normal value. Only 33% cases with pseudocholinesterase level less than 10% were treated with pralidoxime. CONCLUSIONS: The initial dose of Pralidoxime used was 1 gm followed by maintenance dose of 500mg 6 hourly, the doses prescribed were less than WHO recommended doses. Keywords: cholinesterase, emergency, organophosphorus,poisoning, Pralidoxime. http://jnma.com.np/jnma/index.php/jnma/article/view/62 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
N R Simkhada KK Kafle PN Prasad |
spellingShingle |
N R Simkhada KK Kafle PN Prasad Pralidoxime in organophosphorus poisoning Journal of Nepal Medical Association |
author_facet |
N R Simkhada KK Kafle PN Prasad |
author_sort |
N R Simkhada |
title |
Pralidoxime in organophosphorus poisoning |
title_short |
Pralidoxime in organophosphorus poisoning |
title_full |
Pralidoxime in organophosphorus poisoning |
title_fullStr |
Pralidoxime in organophosphorus poisoning |
title_full_unstemmed |
Pralidoxime in organophosphorus poisoning |
title_sort |
pralidoxime in organophosphorus poisoning |
publisher |
Nepal Medical Association |
series |
Journal of Nepal Medical Association |
issn |
0028-2715 1815-672X |
publishDate |
2010-12-01 |
description |
INTRODUCTION:
Pralidoxime are enzyme reactivator that are known to reactivate the phosphorylated acetylcholinesterase by binding to the organophosphorus molecule. The use of oximes in acute organophosphorus poisoning has been a controversial subjects for over two decades. This study was conducted with the objective to find out the estimation of serum cholinesterase and use of pralidoxime in organophosphorus poisoning.
METHODS:
A prospective analysis of all organophosphorus poisoning cases presented at the Emergency Department, Tribhuvan University Teaching Hospital for seven months was done.
RESULTS:
Out of 26 cases about 60% of poisoning cases were monitored for pseudocholinesterase level. About 50% of them had pseudocholinesterase level within normal limit and 20% had less than 10% of normal value. Only 33% cases with pseudocholinesterase level less than 10% were treated with pralidoxime.
CONCLUSIONS:
The initial dose of Pralidoxime used was 1 gm followed by maintenance dose of 500mg 6 hourly, the doses prescribed were less than WHO recommended doses.
Keywords: cholinesterase, emergency, organophosphorus,poisoning, Pralidoxime.
|
url |
http://jnma.com.np/jnma/index.php/jnma/article/view/62 |
work_keys_str_mv |
AT nrsimkhada pralidoximeinorganophosphoruspoisoning AT kkkafle pralidoximeinorganophosphoruspoisoning AT pnprasad pralidoximeinorganophosphoruspoisoning |
_version_ |
1725973524460339200 |